Ajooni Biotech Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Revenue	2,146	1,824	1,147	801.15	744.88	740.38
Other Revenue	-3.77	-0	-	-0	-	-
Revenue	2,142	1,824	1,147	801.15	744.88	740.38
Revenue Growth	74.20%	59.02%	43.16%	7.55%	0.61%	45.06%
Cost of Revenue	1,765	1,479	970.28	703.5	657.43	640.13
Gross Profit	377.39	344.5	176.64	97.65	87.45	100.24
Selling, General & Admin	249.64	245.81	123.88	64.3	50.88	56.03
Other Operating Expenses	46.07	22.81	13.97	5.67	6.8	11.57
Operating Expenses	323.32	290.68	148.78	78.71	67.73	78.7
Operating Income	54.07	53.82	27.86	18.94	19.72	21.54
Interest Expense	-3.98	-	-	-	-	-
Interest & Investment Income	12.6	12.6	8.88	5.06	2.05	0.01
Other Non Operating Income (Expenses)	-6.94	-6.94	-3.34	-5.29	-4.77	-5.4
EBT Excluding Unusual Items	55.76	59.49	33.4	18.7	16.99	16.15
Gain (Loss) on Sale of Investments	2.88	2.88	11.64	-	-	-
Gain (Loss) on Sale of Assets	0.93	0.93	0.02	-	-	-
Other Unusual Items	-5.91	-5.91	-1.76	-1.95	-1.23	-1.54
Pretax Income	53.66	57.39	43.3	29.96	15.77	14.61
Income Tax Expense	13.93	14.16	9.57	8.35	4.52	4.12
Net Income	39.73	43.22	33.72	21.61	11.25	10.49
Net Income to Common	39.73	43.22	33.72	21.61	11.25	10.49
Net Income Growth	7.80%	28.17%	56.04%	92.16%	7.24%	181.14%
Shares Outstanding (Basic)	172	172	172	88	60	51
Shares Outstanding (Diluted)	172	172	172	88	60	51
Shares Change	-	-	96.59%	46.51%	18.35%	1.00%
EPS (Basic)	0.23	0.25	0.20	0.25	0.19	0.21
EPS (Diluted)	0.23	0.25	0.20	0.25	0.19	0.21
EPS Growth	-	27.69%	-20.63%	31.16%	-9.39%	180.50%

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Free Cash Flow	-	-237.62	-340.05	173.09	-69.39	15.6
Free Cash Flow Per Share	-	-1.38	-1.97	1.98	-1.16	0.31
Gross Margin	17.62%	18.89%	15.40%	12.19%	11.74%	13.54%
Operating Margin	2.52%	2.95%	2.43%	2.36%	2.65%	2.91%
Profit Margin	1.85%	2.37%	2.94%	2.70%	1.51%	1.42%
Free Cash Flow Margin	-	-13.03%	-29.65%	21.61%	-9.32%	2.11%
EBITDA	78.91	75.89	38.8	27.68	29.77	31.24
EBITDA Margin	3.68%	4.16%	3.38%	3.45%	4.00%	4.22%
D&A For EBITDA	24.85	22.06	10.94	8.74	10.05	9.7
EBIT	54.07	53.82	27.86	18.94	19.72	21.54
EBIT Margin	2.52%	2.95%	2.43%	2.36%	2.65%	2.91%
Effective Tax Rate	25.96%	24.68%	22.11%	27.87%	28.68%	28.22%
Revenue as Reported	2,166	1,848	1,168	823.08	747.82	740.76
Advertising Expenses	-	2.92	2.5	0.36	0.19	0.35